Nuo Therapeutics Overview
- Year Founded
-
1987
- Status
-
Public
- Employees
-
10
- Stock Symbol
-
AURX
- Investments
-
3
- Share Price
-
$1.07
- (As of Thursday Closing)
Nuo Therapeutics General Information
Description
Nuo Therapeutics Inc is a commercial-stage medical device company engaged in developing and marketing products for chronic wound care. The company operates as a single segment focused on regenerative therapies that utilize autologous (patient-derived) biological materials to promote natural healing. Its primary commercial product is the Aurix System, a point-of-care technology that produces platelet-rich plasma (PRP) therapy from a patient's own blood for use in the treatment of chronic wounds.
Contact Information
Website
www.nuot.comCorporate Office
- 207A Perry Parkway
- Suite 1
- Gaithersburg, MD 20877
- United States
Corporate Office
- 207A Perry Parkway
- Suite 1
- Gaithersburg, MD 20877
- United States
Nuo Therapeutics Stock Performance
As of 19-Nov-2026, Nuo Therapeutics’s stock price is $1.07. Its current market cap is $52.1M with 48.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.07 | $1.09 | $0.77 - $2.29 | $52.1M | 48.6M | 7.08K | -$0.04 |
Nuo Therapeutics Financials Summary
As of 30-Sep-2026, Nuo Therapeutics has a trailing 12-month revenue of $6.03M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 61,903 | 94,313 | 64,733 | 22,968 |
| Revenue | 6,034 | 3,314 | 1,365 | 609 |
| EBITDA | (1,369) | (2,354) | (2,228) | (3,063) |
| Net Income | (1,899) | (2,512) | (2,324) | (3,171) |
| Total Assets | 2,730 | 1,846 | 1,190 | 1,878 |
| Total Debt | 1,841 | 597 | 164 | 256 |
Nuo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nuo Therapeutics Comparisons
Industry
Financing
Details
Nuo Therapeutics Competitors (7)
One of Nuo Therapeutics’s 7 competitors is Mimedx Group, a Corporation company based in Marietta, GA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mimedx Group | Corporation | Marietta, GA | ||||
| TELA Bio | Formerly VC-backed | Malvern, PA | ||||
| Sanara MedTech | Corporation | Fort Worth, TX | ||||
| Mölnlycke Health Care | Private Equity-Backed | Mölndal, Sweden | ||||
| Reapplix | Venture Capital-Backed | Birkerod, Denmark |
Nuo Therapeutics Patents
Nuo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2010308416-A1 | Kit for separation of biological fluids | Active | 13-Oct-2009 | ||
| AU-2010308416-B2 | Kit for separation of biological fluids | Inactive | 13-Oct-2009 | ||
| CA-2775352-A1 | Kit for separation of biological fluids | Active | 13-Oct-2009 | ||
| CA-2775352-C | Kit for separation of biological fluids | Active | 13-Oct-2009 | ||
| EP-2488229-A2 | Kit for separation of biological fluids | Active | 13-Oct-2009 | B01L3/5021 |
Nuo Therapeutics Signals
Nuo Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nuo Therapeutics Investments & Acquisitions (3)
Nuo Therapeutics’s most recent deal was a Merger/Acquisition with Aldagen for . The deal was made on 09-Feb-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Aldagen | 09-Feb-2012 | Merger/Acquisition | Drug Discovery | ||
| Sorin Group (blood processing kits) | 12-Apr-2010 | Corporate Asset Purchase | Buildings and Property | ||
| Informatix Holdings | 04-Nov-1999 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Nuo Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Nuo Therapeutics FAQs
-
When was Nuo Therapeutics founded?
Nuo Therapeutics was founded in 1987.
-
Where is Nuo Therapeutics headquartered?
Nuo Therapeutics is headquartered in Gaithersburg, MD.
-
What is the size of Nuo Therapeutics?
Nuo Therapeutics has 10 total employees.
-
What industry is Nuo Therapeutics in?
Nuo Therapeutics’s primary industry is Surgical Devices.
-
Is Nuo Therapeutics a private or public company?
Nuo Therapeutics is a Public company.
-
What is Nuo Therapeutics’s stock symbol?
The ticker symbol for Nuo Therapeutics is AURX.
-
What is the current stock price of Nuo Therapeutics?
As of 19-Nov-2026 the stock price of Nuo Therapeutics is $1.07.
-
What is the current market cap of Nuo Therapeutics?
The current market capitalization of Nuo Therapeutics is $52.1M.
-
What is Nuo Therapeutics’s current revenue?
The trailing twelve month revenue for Nuo Therapeutics is $6.03M.
-
Who are Nuo Therapeutics’s competitors?
Mimedx Group, TELA Bio, Sanara MedTech, Mölnlycke Health Care, and Reapplix are some of the 7 competitors of Nuo Therapeutics.
-
What is Nuo Therapeutics’s annual earnings per share (EPS)?
Nuo Therapeutics’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process